金吾财讯 | 智云健康(09955)宣布，集团自主研发的糖尿病数字药产品ClouDT-01，已于近期通过中国浙江省药品监督管理局审批，且获得其颁发的中国医疗器械注册证。ClouDT-01是集团数字药研发管线的重要产品。依托公司先进的人工智能大模型、全面的糖尿病服务管理资料库以及丰富的糖尿病临床经验，该产品采用链路技术，深度层析糖尿病的诊疗全流程，精准定位传统治疗未被满足的需求。通过动态图示和即时管理，ClouDT-01旨在促进糖尿病患者进一步临床获益。
金吾财讯 | 智云健康(09955)宣布，集团自主研发的糖尿病数字药产品ClouDT-01，已于近期通过中国浙江省药品监督管理局审批，且获得其颁发的中国医疗器械注册证。ClouDT-01是集团数字药研发管线的重要产品。依托公司先进的人工智能大模型、全面的糖尿病服务管理资料库以及丰富的糖尿病临床经验，该产品采用链路技术，深度层析糖尿病的诊疗全流程，精准定位传统治疗未被满足的需求。通过动态图示和即时管理，ClouDT-01旨在促进糖尿病患者进一步临床获益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.